2BB score and signals
Tarsus Pharmaceuticals, Inc.’s current 2BB score is 67 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 77 | High |
| Momentum | 56 | Stable |
| Financial strength | 52 | Normal |
| Quality | 100 | Very Strong |
| Risk | 36 | Low |
Company facts
| Headquarters | Irvine, California, United States |
| Founded | 2016 |
| Employees | 370 |
| 52-week range | $48.20 – $85.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | -0.1132 | — | $200.18M |
| 2026-11-02 | — | -1.3117 | — | $186.19M |
| 2026-08-06 | — | -0.2139 | — | $172.50M |
| 2026-05-06 | -0.16 | -0.3778 | $145.39M | $150.67M |
Related companies
2BBBullish & Bearish